This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

Jason Meggs Biography and Net Worth

CFO of Syneos Health

Jason Meggs serves as Chief Financial Officer of the Company. He was appointed Chief Financial Officer ("CFO") in May 2018 after serving as Executive Vice President and Interim CFO beginning in February 2018. Prior to his appointment to this role, he served as Executive Vice President and CFO of the Commercial Solutions segment of the Company from August 2017 to February 2018. He also previously served as Executive Vice President, Oncology Operations of the Company from January 2017 to August 2017 and Senior Vice President, Business Finance of the Company from 2014 to 2016. Prior to joining the Company, Mr. Meggs was Global Vice President, Internal Audit, at Quintiles Transnational Corporation, a leading global CRO, from 2013 to 2014 and held a number of finance roles at Quintiles from 2005 to 2013. He began his career as an auditor with Deloitte & Touche LLP and Arthur Anderson LLP, and is a certified public accountant. He currently serves as Treasurer for the ACRO. He received his Bachelor of Science in Business Administration degree with a Major in Accounting from Western Carolina University.

What is Jason M. Meggs' net worth?: The estimated net worth of Jason M. Meggs is at least $2.35 million as of July 18th, 2022. Mr. Meggs owns 54,736 shares of Syneos Health stock worth more than $2,352,553 as of April 24th. This net worth approximation does not reflect any other investments that Mr. Meggs may own. Additionally, Mr. Meggs receives an annual salary of $624,830.00 as CFO at Syneos Health. Learn More about Jason M. Meggs' net worth.
How old is Jason M. Meggs?: Mr. Meggs is currently 47 years old. There are 6 older executives and no younger executives at Syneos Health. The oldest executive at Syneos Health is Ms. Michelle Keefe, CEO & Director, who is 56 years old. Learn More on Jason M. Meggs' age.
What is Jason M. Meggs' salary?: As the CFO of Syneos Health, Inc., Mr. Meggs earns $624,830.00 per year. There are 2 executives that earn more than Mr. Meggs. The highest earning executive at Syneos Health is Ms. Michelle Keefe, CEO & Director, who commands a salary of $876,280.00 per year. Learn More on Jason M. Meggs' salary.
How do I contact Jason M. Meggs?: The corporate mailing address for Mr. Meggs and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected]. Learn More on Jason M. Meggs' contact information.
Has Jason M. Meggs been buying or selling shares of Syneos Health?: Jason M. Meggs has not been actively trading shares of Syneos Health within the last three months. Most recently, Jason M. Meggs sold 7,500 shares of the business's stock in a transaction on Monday, July 18th. The shares were sold at an average price of $72.81, for a transaction totalling $546,075.00. Following the completion of the sale, the chief financial officer now directly owns 54,736 shares of the company's stock, valued at $3,985,328.16. Learn More on Jason M. Meggs' trading history.
Who are Syneos Health's active insiders?: Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Jason M. Meggs Insider Trading History at Syneos Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/18/2022	Sell	7,500	$72.81	$546,075.00	54,736
9/3/2021	Sell	9,223	$95.00	$876,185.00	51,478
7/6/2021	Sell	660	$90.00	$59,400.00	60,741
6/30/2021	Sell	4,668	$90.00	$420,120.00
4/15/2021	Sell	6,000	$84.00	$504,000.00	60,701
1/6/2021	Sell	5,552	$72.00	$399,744.00	64,503
11/27/2020	Sell	4,062	$67.00	$272,154.00	66,003
11/24/2020	Sell	1,938	$67.00	$129,846.00	70,065
3/20/2020	Buy	3,555	$36.74	$130,610.70	63,784
12/17/2018	Buy	3,650	$41.25	$150,562.50

Jason M. Meggs Buying and Selling Activity at Syneos Health

Syneos Health Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Today's Range

Now: $42.98

$42.97

$42.99

50 Day Range

MA: $42.86

$42.48

$42.98

2 Week Range

Now: $42.98

$22.89

$52.23

Volume

7,386,200 shs

Average Volume

1,924,736 shs

Market Capitalization

$4.46 billion

P/E Ratio

62.29

Dividend Yield

N/A

Beta

1.58

This Apple-like Innovator is Revolutionizing Healthcare

From Wall Street Star | Ad